Trial intelligence / Profile preview

Topical Bupivacaine for Post-Tonsillectomy Pain

NCT04825704Phase 3Completed

Sponsor
Nordlandssykehuset
Start
Oct 2021
Primary completion
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bupivacaine in postoperative pain, sponsored by Nordlandssykehuset. Started Oct 2021; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04825704.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04825704.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call